An ultrastructural investigation of tumors undergoing regression mediated by immunotherapy

dc.contributor.authorWestwood, Jennifer A
dc.contributor.authorEllis, Sarah
dc.contributor.authorDanne, Jill
dc.contributor.authorJohnson, Chad
dc.contributor.authorOorschot, Viola
dc.contributor.authorRamm, Georg
dc.contributor.authorTscharke, David
dc.contributor.authorDavenport, Alexander J
dc.contributor.authorWhisstock, James C
dc.contributor.authorDarcy, Phillip K
dc.contributor.authorKershaw, Michael H
dc.contributor.authorSlaney, Clare Y
dc.date.accessioned2022-12-08T00:08:58Z
dc.date.available2022-12-08T00:08:58Z
dc.date.issued2017
dc.date.updated2021-11-28T07:32:33Z
dc.description.abstractWhile immunotherapy employing chimeric antigen receptor (CAR) T cells can be effective against a variety of tumor types, little is known about what happens within the tumor at an ultrastructural level during tumor regression. Here, we used transmission electron microscopy to investigate morphologic and cellular features of tumors responding to immunotherapy composed of adoptive transfer of dual-specific CAR T cells and a vaccine, supported by preconditioning irradiation and interleukin-2. Tumors responded rapidly, and large areas of cell death were apparent by 4 days after treatment. The pleomorphic and metabolically active nature of tumor cells and phagocytic activity of macrophages were apparent in electron microscopic images of tumors prior to treatment. Following treatment, morphologic features of various types of tumor cell death were observed, including apoptosis, paraptosis and necrosis. Large numbers of lipid droplets were evident in tumor cells undergoing apoptosis. Macrophages were the predominant leukocyte type infiltrating tumors before treatment. Macrophages decreased in frequency and number after treatment, whereas an increasing accumulation of neutrophils and T lymphocytes was observed following treatment. Phagocytic activity of macrophages and neutrophils was apparent, while T cells could be observed in close association with tumor cells with potential immunological synapses present. These observations highlight the cellular composition and ultrastructural appearance of tumors undergoing regression mediated by immunotherapy.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1949-2553en_AU
dc.identifier.urihttp://hdl.handle.net/1885/281639
dc.language.isoen_AUen_AU
dc.provenanceThis is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_AU
dc.publisherImpact Journalsen_AU
dc.rights© 2017 The authorsen_AU
dc.rights.licenseCreative Commons Attribution licenceen_AU
dc.rights.urihttp://creativecommons.org/licenses/by/3.0en_AU
dc.sourceOncotargeten_AU
dc.subjectelectron microscopyen_AU
dc.subjecttumor regressionen_AU
dc.subjectcancer vaccineen_AU
dc.subjectbreast canceren_AU
dc.subjectapoptosisen_AU
dc.titleAn ultrastructural investigation of tumors undergoing regression mediated by immunotherapyen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.issue70en_AU
local.bibliographicCitation.lastpage115229en_AU
local.bibliographicCitation.startpage115215en_AU
local.contributor.affiliationWestwood, Jennifer A, Cancer Immunology Program, Peter MacCallum Cancer Centeren_AU
local.contributor.affiliationEllis, Sarah, Peter MacCallum Cancer Centreen_AU
local.contributor.affiliationDanne, Jill, University of Melbourneen_AU
local.contributor.affiliationJohnson, Chad, University of Melbourneen_AU
local.contributor.affiliationOorschot, Viola, Monash Universityen_AU
local.contributor.affiliationRamm, Georg, Monash Universityen_AU
local.contributor.affiliationTscharke, David, College of Health and Medicine, ANUen_AU
local.contributor.affiliationDavenport, Alexander J, Cancer Immunology Program, Peter MacCallum Cancer Centeren_AU
local.contributor.affiliationWhisstock, James C, Monash Universityen_AU
local.contributor.affiliationDarcy, Phillip K, Cancer Immunology Program, Peter MacCallum Cancer Centeren_AU
local.contributor.affiliationKershaw, Michael H, Cancer Immunology Program, Peter MacCallum Cancer Centeren_AU
local.contributor.affiliationSlaney, Clare Y, Cancer Immunology Program, Peter MacCallum Cancer Centreen_AU
local.contributor.authoruidTscharke, David, u4334102en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor321104 - Cancer therapy (excl. chemotherapy and radiation therapy)en_AU
local.identifier.absfor320409 - Tumour immunologyen_AU
local.identifier.absseo200105 - Treatment of human diseases and conditionsen_AU
local.identifier.absseo280103 - Expanding knowledge in the biomedical and clinical sciencesen_AU
local.identifier.ariespublicationu4485658xPUB314en_AU
local.identifier.citationvolume8en_AU
local.identifier.doi10.18632/oncotarget.23215en_AU
local.identifier.scopusID2-s2.0-85039759982
local.publisher.urlhttps://www.oncotarget.com/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
An ultrastructural.pdf
Size:
15.7 MB
Format:
Adobe Portable Document Format
Description: